US ELISA Market Insights: Innovation and Demand Transforming the Market Landscape
The United States represents the largest share of the Enzyme-Linked Immunosorbent Assay (ELISA) Market, driven by its advanced healthcare infrastructure, strong biotechnology sector, and extensive investment in medical research. The country continues to witness growing demand for ELISA-based diagnostic tests due to the rising prevalence of chronic diseases, infectious diseases, autoimmune...
0 Commenti
0 condivisioni
508 Views